National Health Care Spending Expected to Grow Five Percent Annually

This article originally appeared here.
Share this content:
United States health expenditures are expected to represent 19.9 percent of gross domestic product by 2025.
United States health expenditures are expected to represent 19.9 percent of gross domestic product by 2025.

(HealthDay News) -- Health care spending is expected to grow at an average annual rate of 5.6 percent from 2016 to 2025, according to a report published online Feb. 15 in Health Affairs.

Sean P. Keehan, from the U.S. Centers for Medicare and Medicaid Services in Baltimore, and colleagues address national health expenditure projections for 2016 to 2025.

The researchers note that for 2016 to 2025, national health expenditures are expected to grow at an annual rate of 5.6 percent; by 2025, expenditures are expected to represent 19.9 percent of the gross domestic product. National health expenditure is expected to have decreased 1.1 percent to 4.8 percent for 2016, resulting from slowing in Medicaid and prescription drug spending growth. Faster projected growth in medical prices is expected to be offset partially by slower projected growth in the use and intensity of medical goods and services for the rest of the projection period, relative to that seen in 2014 to 2016 in association with coverage expansions resulting from the Affordable Care Act. From 2015 to 2025, the insured share of the population is expected to increase from 90.9 to 91.5 percent.

"This analysis finds that under current law and following the recent significant period of transition associated with coverage expansions, health care enrollment and spending trends are projected to revert to being fundamentally driven by changes in economics and demographics," the authors write.

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs